At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BLU BELLUS Health Inc.
Closed 06-30 16:00:00 EDT
14.74
+0.00
0.00%
High14.74
Low14.74
Vol0.00
Open14.74
D1 Closing14.74
Amplitude0.00%
Mkt Cap1.87B
Tradable Cap1.36B
Total Shares126.81M
T/O0.00
T/O Rate0.00%
Tradable Shares92.14M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
ROUTE 60 ARRIVES ON DIGITAL, BLU-RAY™ AND DVD TODAY
BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada.